India, June 10 -- Today's top biotech gainers include Parabilis, following a strong debut on its first day of trading; Shoulder Innovations, which recently issued a rosy outlook for the year; and Clover Health, which won a legal victory in its dispute with the U.S. Department of Health and Human Services, among others.
Read on.
PBLS Makes a Splash
Parabilis Medicines Inc. (PBLS), which made its debut on the Nasdaq on Wednesday, led the pack of gainers, with shares rising 58%.
The company priced its IPO of 33.50 million shares of its common stock for $20.00 per share. The offering, which is scheduled to close on or about June 11, 2026, is expected to rake in gross proceeds of about $670 million.
This clinical-stage biopharmaceutical com...